Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older
- People who have been informed about the study's goals and have signed a consent form agreeing to take part
- People diagnosed with non-small cell lung cancer at stage IIIA, IIIB, or stage IV
- People whose overall health and ability to carry out daily activities falls within an acceptable range, as measured by a standard medical scoring system (confirm with trial site)
- People whose cancer treatment includes a type of therapy that works with the immune system, either on its own or combined with other treatments
- People who have at least one area of cancer that can be measured on scans
- People who have test results available showing the level of a protein called PD-L1 in their cancer cells
Who may not be able to join:
- People who currently have another type of cancer at the same time
- People who have had a different cancer diagnosed within the last 5 years
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +33 3 88 12 84 57
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Predictive value of quantification of cell-free DNA from plasma at the time of the first radiological evaluation, on clinical benefit
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.